F. Dartiguenave

Type de document

Co-auteur

D. Nardelli-Haefliger

P. Jichlinski

L. Derré

M.F. Chevalier

V. Cesson

P. Bohner

D.E. Speiser

S.C. Rodrigues-Dias

I. Lucca

D. Gharbi

L. Villier

M Valerio

S. Trabanelli

T. Tawadros

A.K. Schneider

B. Salomé

S. Rotman

B. Roth

C.A. Rentsch

J. Racle

C. Pieraerts

A. Nobile

S. Nguyen

V. Martin

B. Lhermitte

A.S. Legris

C. Jandus

J. Gourmaud

D. Gfeller

A.S. Fritschi

S. Domingos-Pereira

L. De Leval

R. Burruni

S. Benmerzoug

Date

Source

Serveur académique Lausannois (4)

Mot-clé

cancer (4) Cancer (4) Patients (4) Cancer (4) Bladder (4) Patients (4) survie (3) Treatment (3) T cells (3) Survival (3) Cells (3) Blood (3) spectacle (2) immunité (2) analyse (2) Drama (2) Phenotype (2) Urine (2) Human beings (2) Immunity (2) Immune response--Regulation (2) Expression (2) Drama (2) Cancer--Patients (2) Bacillus (Bacteria) (2) Analysis (2) puits (1) tissu (corporel) (1) temps (durée) (1) thérapie (1)

Documents écrit par F. Dartiguenave (4) | parle de F. Dartiguenave (0)

Siglec-7 May Limit Natural Killer Cell-mediated Antitumor responses in Bladder Cancer Patients.

S. Benmerzoug et al.

Double Positive CD4+CD8+ T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization.

P. Bohner et al. (2019)

Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.

M.F. Chevalier et al.

ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.

M.F. Chevalier et al. (2017)